Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Off-label use of aducanumab for cerebral amyloid angiopathy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Off-label use of aducanumab for cerebral amyloid angiopathy.
Off-label use of aducanumab for cerebral amyloid angiopathy. Lancet Neurol. 2021 08; 20(8):596-597.
View in:
PubMed
subject areas
Aged
Amyloid beta-Peptides
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Cerebral Amyloid Angiopathy
Humans
Off-Label Use
United States
United States Food and Drug Administration
authors with profiles
Julie A. Schneider